Responsibility

Suppliers and Customers

Suppliers

All our products are developed, tested and distributed according to the standard of good practice required by pharmaceutical and device regulators. We only appoint Contract Research Organisations (CROs), Contract Manufacturing Organisations (CMOs) and other third-party vendors that have a high standard of ethics and quality, that comply with good practice guidelines.

Customers

Our reputation depends on our ability to manufacture safe, quality and efficacious products for patients worldwide. We operate recognised quality management systems comprising the BS EN ISO 9001, BS EN ISO 13485:2003 standards, the FDA cGMP and MHRA/TGA GMP standards and good practice guidelines. Our Quality Policy Manual outlines our approach and commitment to quality. Quality is regularly discussed during internal meetings and during personnel training and development to highlight its importance throughout the organisation.

We recently started selling our own approved products for the first time in our Company's history. With this comes a responsibility to new audiences with whom we are now interacting directly, including specialist physicians and patients. We have implemented appropriate policies and training to ensure we comply with all relevant regulations relating to our interactions with healthcare professionals. We have also added a new section to our corporate website dedicated to Healthcare Professionals, incorporating frequently asked questions (FAQs) on each product, a medical enquiry form and medical contact information, which links visitors through to an independent trained medical professional. We have ensured that the details for reporting suspected adverse events are clearly visible on the site. All collateral used in the marketing or sale of our products underwent review through our new Promotional Review Committee, consisting of senior level expertise in Product Marketing, Medical Affairs, Legal and Compliance.

Targets for 2012-13

• Taking responsibility for our supply chain: Formation of a responsible supply chain policy, including written supplier requirements.
• Ensuring patients have fair access to our products: Finalise standard operating procedure to make unlicensed medicinal products available for compassionate use in the situation where there is no distributor in place.